Cargando…

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects

BACKGROUND: Numerous observational studies support the safety and effectiveness of the direct oral anticoagulants (DOAC) for stroke prevention in atrial fibrillation (AF), but these data are often limited to short duration of follow-up. We aimed to assess the length of on-treatment follow-up in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutto, David, Siontis, George C.M., Noseworthy, Peter A., Siontis, Konstantinos C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157465/ https://www.ncbi.nlm.nih.gov/pubmed/35663450 http://dx.doi.org/10.1016/j.ijcha.2022.101024

Ejemplares similares

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Is Atrial Fibrillation Management as Simple as ABC?
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
por: van Zyl, Martin, et al.
Publicado: (2020)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Intra-procedural anticoagulation protocols for left-sided cardiac ablations: Striking a balance between risk and benefit
por: Siontis, Konstantinos C.
Publicado: (2016)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Development and validation pathways of artificial intelligence tools evaluated in randomised clinical trials
por: Siontis, George C M, et al.
Publicado: (2021)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
por: van der Horst, Sabine F. B., et al.
Publicado: (2023)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda D., et al.
Publicado: (2021)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
por: Pham, Phuong N., et al.
Publicado: (2019)

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity
por: Navarro-Almenzar, Begoña, et al.
Publicado: (2021)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023)

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65
por: Han, Sola, et al.
Publicado: (2019)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Cavotricuspid isthmus ablation for atrial flutter: Anatomic challenges and troubleshooting
por: Christopoulos, Georgios, et al.
Publicado: (2020)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
por: Said, Ahmad, et al.
Publicado: (2020)

Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta‐analysis
por: Sweda, Romy, et al.
Publicado: (2020)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

QRS complex maximum deflection index in aortic cusp premature ventricular complexes
por: Siontis, Konstantinos C., et al.
Publicado: (2015)

Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations
por: Tripathi, Byomesh, et al.
Publicado: (2019)

Perceptions and Experiences of Atrial Fibrillation Patients on Their Condition and Oral Anticoagulant Treatment
por: Slavenburg, Marcel, et al.
Publicado: (2020)

Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
por: Stoica, Mihai Ciprian, et al.
Publicado: (2021)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pru8q3emg8j72fke3b5888r20p